Mast cell production and response to IL-4 and IL-13

Cytokine

Volumn 75, Issue 1, 2015, Pages 57-61

  McLeod, Jamie J A ^a   Baker, Bianca ^a   Ryan, John J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

IL 13; IL 4; Interleukin 13; Interleukin 4; Mast cells

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; CORTICOSTEROID; CYTOKINE; IL4 PROTEIN, HUMAN; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN-13, HUMAN;

ALLERGY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; HUMAN; IMMUNE RESPONSE; INFECTION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; ANIMAL; ASTHMA; CYTOLOGY; GENE EXPRESSION REGULATION; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE;

ADRENAL CORTEX HORMONES; ANIMALS; ASTHMA; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-4; MAST CELLS; MICE; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION;

EID: 84938746719     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.05.019     Document Type: Review

References (85)

1. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol Rev 1997, 77(4):1033-1079.
2. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M.M., Tsai M. Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005, 23:749-786.
3. Jamur M.C., Grodzki A.C.G., Berenstein E.H., Hamawy M.M., Siraganian R.P., Oliver C. Identification and characterization of undifferentiated mast cells in mouse bone marrow. Blood 2005, 105(11):4282-4289.
4. Brown M.A., Pierce J.H., Watson C.J., Falco J., Ihle J.N., Paul W.E. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 1987, 50(5):809-818.
5. Malaviya R., Abraham S.N. Mast cell modulation of immune responses to bacteria. Immunol Rev 2001, 179:16-24.
6. Malaviya R., Ikeda T., Ross E., Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996, 381(6577):77-80.
7. Malaviya R., Gao Z., Thankavel K., van der Merwe P.A., Abraham S.N. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci USA 1999, 96(14):8110-8115.
8. Malaviya R., Abraham S.N. Interaction of bacteria with mast cells. Method Enzymol 1995, 253:27-43.
9. Malaviya R., Abraham S.N. Clinical implications of mast cell-bacteria interaction. J Mol Med 1998, 76(9):617-623.
10. Marshall J.S., King C.A., McCurdy J.D. Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr Pharm Des 2003, 9(1):11-24.
11. McCurdy J.D., Olynych T.J., Maher L.H., Marshall J.S. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003, 170(4):1625-1629.
12. Marshall J.S., McCurdy J.D., Olynych T. Toll-like receptor-mediated activation of mast cells: implications for allergic disease?. Int Arch Allergy Immunol 2003, 132(2):87-97.
13. Marshall J.S. Mast-cell responses to pathogens: abstract. Nat Rev Immunol 2004, 4:787-799.
14. Echtenacher B., Männel D.N., Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381(6577):75-77.
15. Gilfillan A.M., Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 2006, 6(3):218-230.
16. Plaut M., Pierce J.H., Watson C.J., Hanley-Hyde J., Nordan R.P., Paul W.E. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 1989, 339(6219):64-67.
17. Okayama Y., Semper A., Holgate S.T., Church M.K. Multiple cytokine mRNA expression in human mast cells stimulated via Fc epsilon RI. Int Arch Allergy Immunol 1995, 107(1-3):158-159.
18. Marietta E.V., Chen Y., Weis J.H. Modulation of expression of the anti-inflammatory cytokines interleukin-13 and interleukin-10 by interleukin-3. Eur J Immunol 1996, 26(1):49-56.
19. Fushimi T., Okayama H., Shimura S., Saitoh H., Shirato K. Dexamethasone suppresses gene expression and production of IL-13 by human mast cell line and lung mast cells. J Allergy Clin Immunol 1998, 102(1):134-142.
20. Burd P.R., Thompson W.C., Max E.E., Mills F.C. Activated mast cells produce interleukin 13. J Exp Med 1995, 181(4):1373-1380.
21. Komai-Koma M., Brombacher F., Pushparaj P.N., Arendse B., McSharry C., Alexander J., et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy 2012, 67(9):1118-1126.
22. Hoffmann H.J., Dahl C., Schiøtz P.O., Berglund L., Dahl R. Lectins interact differentially with purified human eosinophils, cultured cord blood-derived mast cells and the myeloid leukaemic cell line AML14.3D10: induction of interleukin-4 secretion is conserved among granulocytes, but is not proportional to agglutination or lectin-glycoprotein interaction. Clin Exp Allergy 2003, 33(7):930-935.
23. Wang M., Saxon A., Diaz-Sanchez D. Early IL-4 production driving Th2 differentiation in a human in vivo allergic model is mast cell derived. Clin Immunol 1999, 90(1):47-54.
24. Toru H., Pawankar R., Ra C., Yata J., Nakahata T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol 1998, 102(3):491-502.
25. Varadaradjalou S., Féger F., Thieblemont N., Hamouda N.B., Pleau J.-M., Dy M., et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003, 33(4):899-906.
26. Li B., Berman J., Tang J.T., Lin T.J. The early growth response factor-1 is involved in stem cell factor (SCF)-induced interleukin 13 production by mast cells, but is dispensable for scf-dependent mast cell growth. J Biol Chem 2007, 282(31):22573-22581.
27. Falanga Y.T., Chaimowitz N.S., Charles N., Finkelman F.D., Pullen N.A., Barbour S., et al. Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis. J Immunol 2012, 188(9):4360-4368.
28. Lee S.A., Fitzgerald S.M., Huang S.K., Li C., Chi D.S., Milhorn D.M., et al. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1β. Am J Respir Cell Mol Biol 2004, 31(3):283-291.
29. Ryan J.J., McReynolds L.J., Keegan A., Wang L.H., Garfein E., Rothman P., et al. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 1996, 4(2):123-132.
30. Cameron L., Hamid Q., Wright E., Nakamura Y., Christodoulopoulos P., Muro S., et al. Local synthesis of {small element of} germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. J Allergy Clin Immunol 2000, 106(1):46-52.
31. Ghaffar O., Laberge S., Jacobson M.R., Lowhagen O., Rak S., Durham S.R., et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell Mol Biol 1997, 17(1):17-24.
32. Sherman M.A., Secor V.H., Brown M.A. IL-4 preferentially activates a novel STAT6 isoform in mast cells. J Immunol 1999, 162(5):2703-2708.
33. Sherman M.A., Secor V.H., Lee S.K., Lopez R.D., Brown M.A. STAT6-independent production of IL-4 by mast cells. Eur J Immunol 1999, 29(4):1235-1242.
34. Henkel G., Brown M.A. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci USA 1994, 91(16):7737-7741.
35. Weiss D.L., Hural J., Tara D., Timmerman L.A., Henkel G., Brown M.A. Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex. Mol Cell Biol 1995, 16(1):228-235.
36. Hock M.B., Brown M.A. Nuclear factor of activated T cells 2 transactivation in mast cells: a novel isoform-specific transactivation domain confers unique FcRI responsiveness. J Biol Chem 2003, 278(29):26695-26703.
37. Gregory G.D., Raju S.S., Winandy S., Brown M.A. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J Clin Invest 2006, 116(5):1327-1336.
38. Solymar D.C., Agarwal S., Bassing C.H., Alt F.W., Rao A. A 3' enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells. Immunity 2002, 17(1):41-50.
39. Yang Y.J., Chen W., Carrigan S.O., Chen W.M., Roth K., Akiyama T., et al. TRAF6 specifically contributes to FcRI-mediated cytokine production but not mast cell degranulation. J Biol Chem 2008, 283(46):32110-32118.
40. Lorentz A., Klopp I., Gebhardt T., Manns M.P., Bischoff S.C. Role of activator protein 1, nuclear factor-κB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells. J Allergy Clin Immunol 2003, 111(5):1062-1068.
41. Gomez G., Gonzalez-Espinosa C., Odom S., Baez G., Cid M.E., Ryan J.J., et al. Impaired FcRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J Immunol 2005, 175(11):7602-7610.
42. LaPorte S.L., Juo Z.S., Vaclavikova J., Colf L.A., Qi X., Heller N.M., et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 2008, 132(2):259-272.
43. Strait R.T., Morris S.C., Smiley K., Urban J.F., Finkelman F.D. IL-4 exacerbates anaphylaxis. J Immunol 2003, 170(7):3835-3842.
44. Nilsson G., Nilsson K. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur J Immunol 1995, 25(3):870-873.
45. Finkelman F.D., Shea-Donohue T., Morris S.C., Gildea L., Strait R., Madden K.B., et al. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev 2004, 201:139-155.
46. Reber L., Da Silva C.A., Frossard N. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur J Pharmacol 2006, 533(1-3):327-340.
47. Gessner A., Mohrs K., Mohrs M. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 2005, 174(2):1063-1072.
48. Madden K.B., Whitman L., Sullivan C., Gause W.C., Urban J.F., Katona I.M., et al. Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol 2002, 169(8):4417-4422.
49. Yu S., Zhang R., Zhu C., Cheng J., Wang H., Wu J. MicroRNA-143 downregulates interleukin-13 receptor alpha1 in human mast cells. IJMS 2013, 14(8):16958-16969.
50. Jiang Y., Kanaoka Y., Feng C., Nocka K., Rao S., Boyce J.A. Cutting edge: interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling. J Immunol 2006, 177(5):2755-2759.
51. Hsieh F.H., Lam B.K., Penrose J.F., Austen K.F., Boyce J.A. T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. J Exp Med 2001, 193(1):123-133.
52. Lorentz A., Wilke M., Sellge G., Worthmann H., Klempnauer J., Manns M.P., et al. IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol 2005, 174(11):6751-6756.
53. Feuser K., Feilhauer K., Staib L., Bischoff S.C., Lorentz A. Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells. Mol Immunol 2011, 48(4):546-552.
54. Huang Z., Coleman J.M., Su Y., Mann M., Ryan J., Shultz L.D., et al. SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner. Cytokine 2005, 29(3):118-124.
55. Oh C.K., Geba G.P., Molfino N. Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev 2010, 19(115):46-54.
56. Sherman M.A., Powell D.R., Brown M.A. IL-4 induces the proteolytic processing of mast Cell STAT6. J Immunol 2002, 169(7):3811-3818.
57. Shelburne C.P., Piekorz R.P., Bouton L.A., Jin Chong.H., Ryan J.J. Mast cell-restricted p70 Stat6 isoform is a product of selective proteolysis. Cytokine 2002, 19(5):218-227.
58. Lorentz A., Bischoff S.C. Regulation of human intestinal mast cells by stem cell factor and IL-4. Immunol Rev 2001, 179:57-60.
59. Bischoff S.C., Sellge G., Lorentz A., Sebald W., Raab R., Manns M.P. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 1999, 96(14):8080-8085.
60. Coleman J.W., Holliday M.R., Kimber I., Zsebo K.M., Galli S.J. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol 1993, 150(2):556-562.
61. Lorentz A., Schuppan D., Gebert A., Manns M.P., Bischoff S.C. Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins. Blood 2002, 99(3):966-972.
62. Olsson N., Taub D.D., Nilsson G. Regulation of mast cell migration by TH1 and TH2 cytokines: identification of tumour necrosis factor-α and interleukin-4 as mast cell chemotaxins. Scand J Immunol 2004, 59(3):267-272.
63. Yamaguchi M., Sayama K., Yano K., Lantz C.S., Noben-Trauth N., Ra C., et al. IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J Immunol 1999, 162(9):5455-5465.
64. Xia H.Z., Du Z., Craig S., Klisch G., Noben-Trauth N., Kochan J.P., et al. Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J Immunol 1997, 159(6):2911-2921.
65. Nilsson G., Miettinen U., Ishizaka T., Ashman L.K., Irani A.M., Schwartz L.B. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 1994, 84(5):1519-1527.
66. Thienemann F., Henz B., Babina M. Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells. Arch Dermatol Res 2004, 296(3).
67. Sillaber C., Strobl H., Bevec D., Ashman L.K., Butterfield J.H., Lechner K., et al. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 1991, 147(12):4224-4228.
68. Karimi K., Redegeld F.A., Heijdra B., Nijkamp F.P. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Exp Hematol 1999, 27(4):654-662.
69. Eklund K.K., Ghildyal N., Austen K.F., Stevens R.L. Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases. J Immunol 1993, 151(8):4266-4273.
70. Oskeritzian C.A., Wang Z., Kochan J.P., Grimes M., Du Z., Chang H.W., et al. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J Immunol 1999, 163(9):5105-5115.
71. Hu Z.-Q., Zenda N., Shimamura T. Down-regulation by IL-4 and up-regulation by IFN-gamma of mast cell induction from mouse spleen cells. J Immunol 1996, 156(10):3925-3931.
72. Bailey D.P., Kashyap M., Mirmonsef P., Bouton L.A., Domen J., Zhu J., et al. Interleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondrial pathway. Exp Hematol 2004, 32(1):52-59.
73. Metcalfe D.D., Peavy R.D., Gilfillan A.M. Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol 2009, 124(4):639-646. [quiz 647-8].
74. Speiran K., Bailey D.P., Fernando J., Macey M., Barnstein B., Kolawole M., et al. Endogenous suppression of mast cell development and survival by IL-4 and IL-10. J Leukoc Biol 2009, 85(5):826-836.
75. Mirmonsef P., Shelburne C.P., Fitzhugh Yeatman.C., Chong H.J., Ryan J.J. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase. J Immunol 1999, 163(5):2530-2539.
76. Ryan J.J., DeSimone S., Klisch G., Shelburne C., McReynolds L.J., Han K., et al. IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6-dependent mechanism. J Immunol 1998, 161(12):6915-6923.
77. Chong H.J., Andrew Bouton L., Bailey D.P., Wright H., Ramirez C., Gharse A., et al. IL-4 selectively enhances FcγRIII expression and signaling on mouse mast cells. Cell Immunol 2003, 224(2):65-73.
78. Yeatman C.F., Jacobs-Helber S.M., Mirmonsef P., Gillespie S.R., Bouton L.A., Collins H.A., et al. Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J Exp Med 2000, 192(8):1093-1104.
79. Bouton L.A., Ramirez C.D., Bailey D.P., Yeatman C.F., Yue J., Wright H.V., et al. Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion. Exp Hematol 2004, 32(12):1137-1145.
80. Macey M.R., Sturgill J.L., Morales J.K., Falanga Y.T., Morales J., Norton S.K., et al. IL-4 and TGF-1 counterbalance one another while regulating mast cell homeostasis. J Immunol 2010, 184(9):4688-4695.
81. Khodoun M., Lewis C., Yang J.Q., Orekov T., Potter C., Wynn T., et al. Differences in expression, affinity, and function of soluble (s)IL-4R and sIL-13R 2 suggest opposite effects on allergic responses. J Immunol 2007, 179(10):6429-6438.
82. Enoksson M., Moller-Westerberg C., Wicher G., Fallon P.G., Forsberg-Nilsson K., Lunderius-Andersson C., et al. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent. Blood 2013, 121(3):530-536.
83. Aoki I., Itoh S., Yokota S., Tanaka S., Ishii N., Okuda K., et al. Contribution of mast cells to the T helper 2 response induced by simultaneous subcutaneous and oral immunization. Immunology 1999, 98(4):519-524.
84. Ho L.H., Ohno T., Oboki K., Kajiwara N., Suto H., Iikura M., et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol 2007, 82(6):1481-1490.
85. Hueber A.J., Alves-Filho J.C., Asquith D.L., Michels C., Millar N.L., Reilly J.H., et al. IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur J Immunol 2011, 41(8):2229-2237.